Results 11 to 20 of about 10,687 (156)

CTCs in Metastatic Breast Cancer

open access: yes, 2012
Circulating tumor cells (CTCs), enumerated by the Food and Drugs Administration-cleared CellSearch(®) system, are an independent prognostic factor of progression-free survival (PFS) and overall survival (OS) in metastatic breast cancer (MBC) patients.
Giordano A., Cristofanilli M.
openaire   +4 more sources

The Role of CTCs as Tumor Biomarkers

open access: yes, 2015
Detection of Circulating Tumor Cells (CTCs) in peripheral blood can serve as a "liquid biopsy" approach and as a source of valuable tumor markers. CTCs are rare, and thus their detection, enumeration and molecular characterization are very challenging.
Lianidou, E.S., Markou, A., Strati, A.
core   +5 more sources

Magnetic Particles for CTC Enrichment [PDF]

open access: yesCancers, 2020
Here, we review the characteristics and synthesis of magnetic nanoparticles (MNPs) and place these in the context of their usage in the immunomagnetic enrichment of Circulating Tumor Cells (CTCs). The importance of the different characteristics is explained, the need for a very specific enrichment is emphasized and different (commercial) magnetic ...
Peng Liu   +3 more
openaire   +3 more sources

Computation with Narrow CTCs [PDF]

open access: yes, 2011
We examine some variants of computation with closed timelike curves (CTCs), where various restrictions are imposed on the memory of the computer, and the information carrying capacity and range of the CTC. We give full characterizations of the classes of languages recognized by polynomial time probabilistic and quantum computers that can send a single ...
A. C. Cem Say, Abuzer Yakaryilmaz
openaire   +3 more sources

Transcriptomic Analysis of CTCs

open access: yes, 2023
Circulating tumor cells (CTCs), the “seeds” of fatal metastasis, intravasate into the bloodstream throughout the early stages of cancer, promoting the generation of micrometastatic reservoirs, some of which ultimately evolve to metastatic tumors.
Vishnoi, Monika   +2 more
core   +1 more source

Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm [PDF]

open access: yes, 2023
Circulating Tumor Cells (CTCs) are considered a prognostic marker in pancreatic cancer. In this study we present a new approach for counting CTCs and CTC clusters in patients with pancreatic cancer using the IsofluxTM System with the Hough transform ...
Padillo-Ruíz, Javier   +23 more
core   +1 more source

Towards A Test Paths Generation Method for CTCS Level Transition [PDF]

open access: yes, 2020
Test case is an important basis for correctness and safety verification of Chinese Train Control System (CTCS). Focusing on the test cases generation method of UPPAAL which is widely used in CTCS testing activity, the problems are analyzed, and an ...
Yadong ZHANG   +4 more
core   +3 more sources

LV-CTC: Non-Autoregressive ASR With CTC and Latent Variable Models

open access: yes2023 IEEE Automatic Speech Recognition and Understanding Workshop (ASRU), 2023
Non-autoregressive (NAR) models for automatic speech recognition (ASR) aim to achieve high accuracy and fast inference by simplifying the autoregressive (AR) generation process of conventional models. Connectionist temporal classification (CTC) is one of the key techniques used in NAR ASR models.
Yuya Fujita   +3 more
openaire   +2 more sources

Bayes risk CTC: Controllable CTC alignment in Sequence-to-Sequence tasks

open access: yesCoRR, 2022
Sequence-to-Sequence (seq2seq) tasks transcribe the input sequence to a target sequence. The Connectionist Temporal Classification (CTC) criterion is widely used in multiple seq2seq tasks. Besides predicting the target sequence, a side product of CTC is to predict the alignment, which is the most probable input-long sequence that specifies a hard ...
Jinchuan Tian   +5 more
openaire   +4 more sources

Immunofluorescence Images of Circulating Tumor Cells (CTCs)

open access: yes, 2022
Immunofluorescence images of CTCs from paired blood (PB, ID 5152*) and bone marrow samples (BMA, ID 5151*) of an aggressive prostate cancer patient. Images are grouped by subtypes of CTCs defined based on the phenotypic features.
SHOUJIE CHAI (12432699)
core   +1 more source

Home - About - Disclaimer - Privacy